| Health Care Technology Industry | Healthcare Sector | - CEO | HKEX Exchange | - ISIN |
| China Country | 3,361 Employees | - Last Dividend | - Last Split | - IPO Date |
Founded in 1983 and headquartered in Beijing, China, China Isotope & Radiation Corporation (CIRC) operates at the forefront of the nuclear medicine and irradiation service industries in China. As a crucial subsidiary of China National Nuclear Corporation, CIRC harnesses nuclear technology to improve healthcare and industrial processes through its comprehensive portfolio of products and services. The company's operations are segmented into five main areas: Pharmaceuticals, Radioactive Source Products, Irradiation, Radiation Therapy Equipment and Related Services, and Independent Clinical Medical and Laboratory Services and Other Businesses. Through its diversified segments, CIRC is committed to advancing research, development, manufacture, and sale of radiopharmaceuticals for diagnostic and therapeutic applications, offering sterile irradiation services for various industries, and supplying cutting-edge radiation therapy equipment. The company's dedication to innovation, quality, and safety drives its contributions to medical science and various industrial domains.
These products are developed for the diagnosis and treatment of various diseases, utilizing the latest advances in nuclear medicine technology. CIRC's diverse range of radiopharmaceuticals includes agents for PET and SPECT imaging, offering precise images of the body’s internal structure and function to guide diagnoses and therapeutic decisions.
Specialized in diagnostic applications, the Urea Breath Test (UBT) kits and analyzers provided by CIRC are designed for the detection of Helicobacter pylori infection, a common cause of peptic ulcers and gastritis. This non-invasive diagnostic method enhances patient comfort and diagnostic efficiency.
These products are used for the detection and quantification of specific antigens or antibodies in samples, serving a crucial role in the diagnosis of various conditions. CIRC’s immunoassay products leverage advanced technologies to ensure high sensitivity and specificity.
Providing a range of radioactive source products and related technical services for both medical and industrial applications. These include sources for cancer therapy, non-destructive testing, and for use in research and development activities.
CIRC offers sterilization irradiation services for medical devices, food, traditional Chinese medicine, and cosmetics, employing gamma rays and other irradiation methods. The company also provides EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities, contributing to safer medical and consumer products.
This segment encompasses the sale and maintenance of advanced radiation therapy equipment for cancer treatment, including after-sale support. CIRC leverages cutting-edge technology to offer effective solutions for oncological care.
Offering laboratory services that utilize nuclear technology for various industrial applications and medical product analysis. This includes providing comprehensive clinical tests and analyses to support the healthcare and nuclear industries.